Muneaki Shimada

ORCID: 0000-0003-1826-6723 · 10 papers in corpus
observational 2026
Cancer Immunology, Immunotherapy ·doi:10.1007/s00262-026-04324-z

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

diagnostic-accuracy 2026
Journal of translational medicine ·doi:10.1186/s12967-026-08539-7

BACKGROUND: Early detection of epithelial ovarian cancer (EOC) remains a major clinical challenge. Although serum tumor markers are widely used for detection, their diagnostic performance remains limited. We previously developed a comprehen…

case-report 2026
Journal of medical case reports ·doi:10.1186/s13256-026-06317-z

BACKGROUND: Peritoneal defects of the broad ligament of the uterus are uncommon anatomical abnormalities that may be congenital or acquired. Situs inversus totalis is a congenital condition characterized by a complete mirror-image arrangeme…

other 2025
International journal of molecular sciences ·doi:10.3390/ijms26125435

Epithelial ovarian cancer (EOC) is diagnosed at an advanced stage in over half of the patients and its prognosis remains unfavorable. CA125, one of the most frequent positive tumor markers in patients with EOC, has certain limitations. Ther…

diagnostic-accuracy 2024
Scientific reports ·doi:10.1038/s41598-024-70228-6

Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new method, named Comprehe…

diagnostic-accuracy 2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30090597

BACKGROUND: Endometrial cancer is one of the most common gynecological malignancies. Because the findings mentioned in radiogram interpretation reports issued by diagnostic radiologists influence treatment strategies, we aimed to evaluate t…

other 2021
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100847

OBJECTIVE: Ovarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The c…

review 2017
Journal of gynecologic oncology ·doi:10.3802/jgo.2017.28.e54

There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and tr…

2005
case-report 2003
Gynecologic Oncology ·doi:10.1016/j.ygyno.2003.08.005

BACKGROUND: The risk of ovarian cancer increases in women with a long history of ovarian endometriosis, particularly in postmenopausal women. We present here a case of malignant transformation of endometriosis occurring over a short time in…